nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0222	0.158	CbGeAlD
Frovatriptan—HTR1D—telencephalic ventricle—Alzheimer's disease	0.0215	0.153	CbGeAlD
Frovatriptan—HTR1A—telencephalic ventricle—Alzheimer's disease	0.0179	0.128	CbGeAlD
Frovatriptan—HTR1B—blood vessel—Alzheimer's disease	0.011	0.0783	CbGeAlD
Frovatriptan—HTR1D—blood vessel—Alzheimer's disease	0.0106	0.0758	CbGeAlD
Frovatriptan—HTR1B—forebrain—Alzheimer's disease	0.00579	0.0413	CbGeAlD
Frovatriptan—HTR1D—forebrain—Alzheimer's disease	0.0056	0.04	CbGeAlD
Frovatriptan—HTR1B—telencephalon—Alzheimer's disease	0.00532	0.038	CbGeAlD
Frovatriptan—HTR1D—telencephalon—Alzheimer's disease	0.00515	0.0368	CbGeAlD
Frovatriptan—HTR1A—forebrain—Alzheimer's disease	0.00467	0.0333	CbGeAlD
Frovatriptan—HTR1A—telencephalon—Alzheimer's disease	0.00429	0.0307	CbGeAlD
Frovatriptan—HTR1B—nervous system—Alzheimer's disease	0.00314	0.0224	CbGeAlD
Frovatriptan—HTR1D—nervous system—Alzheimer's disease	0.00304	0.0217	CbGeAlD
Frovatriptan—HTR1B—central nervous system—Alzheimer's disease	0.00302	0.0216	CbGeAlD
Frovatriptan—HTR1D—central nervous system—Alzheimer's disease	0.00293	0.0209	CbGeAlD
Frovatriptan—HTR1A—nervous system—Alzheimer's disease	0.00254	0.0181	CbGeAlD
Frovatriptan—HTR1A—central nervous system—Alzheimer's disease	0.00244	0.0174	CbGeAlD
Frovatriptan—HTR1B—brain—Alzheimer's disease	0.0024	0.0171	CbGeAlD
Frovatriptan—HTR1A—cerebellum—Alzheimer's disease	0.00239	0.017	CbGeAlD
Frovatriptan—HTR1D—brain—Alzheimer's disease	0.00233	0.0166	CbGeAlD
Frovatriptan—HTR1A—brain—Alzheimer's disease	0.00194	0.0138	CbGeAlD
Frovatriptan—Flatulence—Galantamine—Alzheimer's disease	0.00136	0.00186	CcSEcCtD
Frovatriptan—Sweating increased—Memantine—Alzheimer's disease	0.00135	0.00186	CcSEcCtD
Frovatriptan—Tension—Galantamine—Alzheimer's disease	0.00135	0.00185	CcSEcCtD
Frovatriptan—Dysgeusia—Galantamine—Alzheimer's disease	0.00135	0.00185	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00135	0.00184	CcSEcCtD
Frovatriptan—Myocardial infarction—Donepezil—Alzheimer's disease	0.00134	0.00183	CcSEcCtD
Frovatriptan—Nervousness—Galantamine—Alzheimer's disease	0.00134	0.00183	CcSEcCtD
Frovatriptan—Back pain—Galantamine—Alzheimer's disease	0.00133	0.00182	CcSEcCtD
Frovatriptan—Conjunctivitis—Donepezil—Alzheimer's disease	0.00133	0.00182	CcSEcCtD
Frovatriptan—Sweating increased—Rivastigmine—Alzheimer's disease	0.00132	0.00181	CcSEcCtD
Frovatriptan—Muscle spasms—Galantamine—Alzheimer's disease	0.00132	0.00181	CcSEcCtD
Frovatriptan—Tremor—Galantamine—Alzheimer's disease	0.00129	0.00177	CcSEcCtD
Frovatriptan—Epistaxis—Donepezil—Alzheimer's disease	0.00129	0.00176	CcSEcCtD
Frovatriptan—Pollakiuria—Memantine—Alzheimer's disease	0.00128	0.00176	CcSEcCtD
Frovatriptan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00128	0.00175	CcSEcCtD
Frovatriptan—Agitation—Galantamine—Alzheimer's disease	0.00126	0.00173	CcSEcCtD
Frovatriptan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00126	0.00172	CcSEcCtD
Frovatriptan—Bradycardia—Donepezil—Alzheimer's disease	0.00125	0.00171	CcSEcCtD
Frovatriptan—Malaise—Galantamine—Alzheimer's disease	0.00124	0.0017	CcSEcCtD
Frovatriptan—Vertigo—Galantamine—Alzheimer's disease	0.00124	0.00169	CcSEcCtD
Frovatriptan—Depression—Memantine—Alzheimer's disease	0.00124	0.00169	CcSEcCtD
Frovatriptan—Syncope—Galantamine—Alzheimer's disease	0.00123	0.00169	CcSEcCtD
Frovatriptan—Haemoglobin—Donepezil—Alzheimer's disease	0.00123	0.00169	CcSEcCtD
Frovatriptan—Rhinitis—Donepezil—Alzheimer's disease	0.00123	0.00168	CcSEcCtD
Frovatriptan—Haemorrhage—Donepezil—Alzheimer's disease	0.00122	0.00168	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00122	0.00167	CcSEcCtD
Frovatriptan—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00122	0.00167	CcSEcCtD
Frovatriptan—Palpitations—Galantamine—Alzheimer's disease	0.00122	0.00167	CcSEcCtD
Frovatriptan—Pharyngitis—Donepezil—Alzheimer's disease	0.00122	0.00167	CcSEcCtD
Frovatriptan—Myocardial infarction—Memantine—Alzheimer's disease	0.00121	0.00166	CcSEcCtD
Frovatriptan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00121	0.00166	CcSEcCtD
Frovatriptan—Loss of consciousness—Galantamine—Alzheimer's disease	0.00121	0.00166	CcSEcCtD
Frovatriptan—Depression—Rivastigmine—Alzheimer's disease	0.00121	0.00166	CcSEcCtD
Frovatriptan—Conjunctivitis—Memantine—Alzheimer's disease	0.0012	0.00165	CcSEcCtD
Frovatriptan—Urethral disorder—Donepezil—Alzheimer's disease	0.0012	0.00165	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00119	0.00164	CcSEcCtD
Frovatriptan—Convulsion—Galantamine—Alzheimer's disease	0.00119	0.00163	CcSEcCtD
Frovatriptan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00119	0.00163	CcSEcCtD
Frovatriptan—Visual impairment—Donepezil—Alzheimer's disease	0.00118	0.00162	CcSEcCtD
Frovatriptan—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00118	0.00161	CcSEcCtD
Frovatriptan—Myalgia—Galantamine—Alzheimer's disease	0.00117	0.00161	CcSEcCtD
Frovatriptan—Chest pain—Galantamine—Alzheimer's disease	0.00117	0.00161	CcSEcCtD
Frovatriptan—Arthralgia—Galantamine—Alzheimer's disease	0.00117	0.00161	CcSEcCtD
Frovatriptan—Epistaxis—Memantine—Alzheimer's disease	0.00117	0.0016	CcSEcCtD
Frovatriptan—Anxiety—Galantamine—Alzheimer's disease	0.00117	0.0016	CcSEcCtD
Frovatriptan—Sinusitis—Memantine—Alzheimer's disease	0.00116	0.00159	CcSEcCtD
Frovatriptan—Discomfort—Galantamine—Alzheimer's disease	0.00116	0.00159	CcSEcCtD
Frovatriptan—Dry mouth—Galantamine—Alzheimer's disease	0.00115	0.00157	CcSEcCtD
Frovatriptan—Epistaxis—Rivastigmine—Alzheimer's disease	0.00114	0.00157	CcSEcCtD
Frovatriptan—Tinnitus—Donepezil—Alzheimer's disease	0.00114	0.00157	CcSEcCtD
Frovatriptan—Sinusitis—Rivastigmine—Alzheimer's disease	0.00114	0.00156	CcSEcCtD
Frovatriptan—Confusional state—Galantamine—Alzheimer's disease	0.00113	0.00155	CcSEcCtD
Frovatriptan—Bradycardia—Memantine—Alzheimer's disease	0.00113	0.00155	CcSEcCtD
Frovatriptan—Haemoglobin—Memantine—Alzheimer's disease	0.00112	0.00153	CcSEcCtD
Frovatriptan—Rhinitis—Memantine—Alzheimer's disease	0.00112	0.00153	CcSEcCtD
Frovatriptan—Haemorrhage—Memantine—Alzheimer's disease	0.00111	0.00152	CcSEcCtD
Frovatriptan—Bradycardia—Rivastigmine—Alzheimer's disease	0.00111	0.00152	CcSEcCtD
Frovatriptan—Hypoaesthesia—Memantine—Alzheimer's disease	0.00111	0.00152	CcSEcCtD
Frovatriptan—Shock—Galantamine—Alzheimer's disease	0.0011	0.00151	CcSEcCtD
Frovatriptan—Pharyngitis—Memantine—Alzheimer's disease	0.0011	0.00151	CcSEcCtD
Frovatriptan—Chills—Donepezil—Alzheimer's disease	0.0011	0.00151	CcSEcCtD
Frovatriptan—Urinary tract disorder—Memantine—Alzheimer's disease	0.0011	0.00151	CcSEcCtD
Frovatriptan—Tachycardia—Galantamine—Alzheimer's disease	0.0011	0.0015	CcSEcCtD
Frovatriptan—Arrhythmia—Donepezil—Alzheimer's disease	0.00109	0.0015	CcSEcCtD
Frovatriptan—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00109	0.0015	CcSEcCtD
Frovatriptan—Rhinitis—Rivastigmine—Alzheimer's disease	0.00109	0.0015	CcSEcCtD
Frovatriptan—Urethral disorder—Memantine—Alzheimer's disease	0.00109	0.00149	CcSEcCtD
Frovatriptan—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00109	0.00149	CcSEcCtD
Frovatriptan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00109	0.00149	CcSEcCtD
Frovatriptan—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00108	0.00148	CcSEcCtD
Frovatriptan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00108	0.00148	CcSEcCtD
Frovatriptan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00107	0.00147	CcSEcCtD
Frovatriptan—Mental disorder—Donepezil—Alzheimer's disease	0.00107	0.00147	CcSEcCtD
Frovatriptan—Visual impairment—Memantine—Alzheimer's disease	0.00107	0.00147	CcSEcCtD
Frovatriptan—Anorexia—Galantamine—Alzheimer's disease	0.00107	0.00147	CcSEcCtD
Frovatriptan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00107	0.00146	CcSEcCtD
Frovatriptan—Malnutrition—Donepezil—Alzheimer's disease	0.00107	0.00146	CcSEcCtD
Frovatriptan—Flatulence—Donepezil—Alzheimer's disease	0.00105	0.00144	CcSEcCtD
Frovatriptan—Visual impairment—Rivastigmine—Alzheimer's disease	0.00105	0.00144	CcSEcCtD
Frovatriptan—Tension—Donepezil—Alzheimer's disease	0.00105	0.00143	CcSEcCtD
Frovatriptan—Dysgeusia—Donepezil—Alzheimer's disease	0.00104	0.00143	CcSEcCtD
Frovatriptan—Tinnitus—Memantine—Alzheimer's disease	0.00104	0.00142	CcSEcCtD
Frovatriptan—Nervousness—Donepezil—Alzheimer's disease	0.00104	0.00142	CcSEcCtD
Frovatriptan—Flushing—Memantine—Alzheimer's disease	0.00103	0.00141	CcSEcCtD
Frovatriptan—Back pain—Donepezil—Alzheimer's disease	0.00103	0.00141	CcSEcCtD
Frovatriptan—Muscle spasms—Donepezil—Alzheimer's disease	0.00103	0.00141	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00102	0.0014	CcSEcCtD
Frovatriptan—Insomnia—Galantamine—Alzheimer's disease	0.00102	0.00139	CcSEcCtD
Frovatriptan—Tinnitus—Rivastigmine—Alzheimer's disease	0.00101	0.00139	CcSEcCtD
Frovatriptan—Flushing—Rivastigmine—Alzheimer's disease	0.00101	0.00138	CcSEcCtD
Frovatriptan—Paraesthesia—Galantamine—Alzheimer's disease	0.00101	0.00138	CcSEcCtD
Frovatriptan—Tremor—Donepezil—Alzheimer's disease	0.000999	0.00137	CcSEcCtD
Frovatriptan—Somnolence—Galantamine—Alzheimer's disease	0.000998	0.00137	CcSEcCtD
Frovatriptan—Chills—Memantine—Alzheimer's disease	0.000998	0.00137	CcSEcCtD
Frovatriptan—Arrhythmia—Memantine—Alzheimer's disease	0.000994	0.00136	CcSEcCtD
Frovatriptan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000989	0.00136	CcSEcCtD
Frovatriptan—Dyspepsia—Galantamine—Alzheimer's disease	0.000988	0.00135	CcSEcCtD
Frovatriptan—Agitation—Donepezil—Alzheimer's disease	0.00098	0.00134	CcSEcCtD
Frovatriptan—Chills—Rivastigmine—Alzheimer's disease	0.000976	0.00134	CcSEcCtD
Frovatriptan—Decreased appetite—Galantamine—Alzheimer's disease	0.000976	0.00134	CcSEcCtD
Frovatriptan—Mental disorder—Memantine—Alzheimer's disease	0.000974	0.00134	CcSEcCtD
Frovatriptan—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000972	0.00133	CcSEcCtD
Frovatriptan—Malnutrition—Memantine—Alzheimer's disease	0.000968	0.00133	CcSEcCtD
Frovatriptan—Fatigue—Galantamine—Alzheimer's disease	0.000968	0.00133	CcSEcCtD
Frovatriptan—Malaise—Donepezil—Alzheimer's disease	0.000962	0.00132	CcSEcCtD
Frovatriptan—Constipation—Galantamine—Alzheimer's disease	0.00096	0.00132	CcSEcCtD
Frovatriptan—Vertigo—Donepezil—Alzheimer's disease	0.000958	0.00131	CcSEcCtD
Frovatriptan—Syncope—Donepezil—Alzheimer's disease	0.000956	0.00131	CcSEcCtD
Frovatriptan—Flatulence—Memantine—Alzheimer's disease	0.000954	0.00131	CcSEcCtD
Frovatriptan—Mental disorder—Rivastigmine—Alzheimer's disease	0.000953	0.00131	CcSEcCtD
Frovatriptan—Tension—Memantine—Alzheimer's disease	0.00095	0.0013	CcSEcCtD
Frovatriptan—Dysgeusia—Memantine—Alzheimer's disease	0.000948	0.0013	CcSEcCtD
Frovatriptan—Malnutrition—Rivastigmine—Alzheimer's disease	0.000947	0.0013	CcSEcCtD
Frovatriptan—Nervousness—Memantine—Alzheimer's disease	0.00094	0.00129	CcSEcCtD
Frovatriptan—Loss of consciousness—Donepezil—Alzheimer's disease	0.000937	0.00128	CcSEcCtD
Frovatriptan—Back pain—Memantine—Alzheimer's disease	0.000937	0.00128	CcSEcCtD
Frovatriptan—Flatulence—Rivastigmine—Alzheimer's disease	0.000933	0.00128	CcSEcCtD
Frovatriptan—Tension—Rivastigmine—Alzheimer's disease	0.000929	0.00127	CcSEcCtD
Frovatriptan—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000928	0.00127	CcSEcCtD
Frovatriptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.000925	0.00127	CcSEcCtD
Frovatriptan—Convulsion—Donepezil—Alzheimer's disease	0.000924	0.00127	CcSEcCtD
Frovatriptan—Nervousness—Rivastigmine—Alzheimer's disease	0.00092	0.00126	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000918	0.00126	CcSEcCtD
Frovatriptan—Back pain—Rivastigmine—Alzheimer's disease	0.000916	0.00126	CcSEcCtD
Frovatriptan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000911	0.00125	CcSEcCtD
Frovatriptan—Chest pain—Donepezil—Alzheimer's disease	0.000908	0.00124	CcSEcCtD
Frovatriptan—Arthralgia—Donepezil—Alzheimer's disease	0.000908	0.00124	CcSEcCtD
Frovatriptan—Myalgia—Donepezil—Alzheimer's disease	0.000908	0.00124	CcSEcCtD
Frovatriptan—Tremor—Memantine—Alzheimer's disease	0.000907	0.00124	CcSEcCtD
Frovatriptan—Anxiety—Donepezil—Alzheimer's disease	0.000905	0.00124	CcSEcCtD
Frovatriptan—Ill-defined disorder—Memantine—Alzheimer's disease	0.000898	0.00123	CcSEcCtD
Frovatriptan—Discomfort—Donepezil—Alzheimer's disease	0.000897	0.00123	CcSEcCtD
Frovatriptan—Agitation—Memantine—Alzheimer's disease	0.00089	0.00122	CcSEcCtD
Frovatriptan—Dry mouth—Donepezil—Alzheimer's disease	0.000888	0.00122	CcSEcCtD
Frovatriptan—Abdominal pain—Galantamine—Alzheimer's disease	0.000888	0.00122	CcSEcCtD
Frovatriptan—Body temperature increased—Galantamine—Alzheimer's disease	0.000888	0.00122	CcSEcCtD
Frovatriptan—Tremor—Rivastigmine—Alzheimer's disease	0.000887	0.00122	CcSEcCtD
Frovatriptan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000879	0.0012	CcSEcCtD
Frovatriptan—Confusional state—Donepezil—Alzheimer's disease	0.000877	0.0012	CcSEcCtD
Frovatriptan—Malaise—Memantine—Alzheimer's disease	0.000873	0.0012	CcSEcCtD
Frovatriptan—Agitation—Rivastigmine—Alzheimer's disease	0.00087	0.00119	CcSEcCtD
Frovatriptan—Vertigo—Memantine—Alzheimer's disease	0.00087	0.00119	CcSEcCtD
Frovatriptan—Syncope—Memantine—Alzheimer's disease	0.000868	0.00119	CcSEcCtD
Frovatriptan—Shock—Donepezil—Alzheimer's disease	0.000856	0.00117	CcSEcCtD
Frovatriptan—Palpitations—Memantine—Alzheimer's disease	0.000856	0.00117	CcSEcCtD
Frovatriptan—Malaise—Rivastigmine—Alzheimer's disease	0.000854	0.00117	CcSEcCtD
Frovatriptan—Vertigo—Rivastigmine—Alzheimer's disease	0.000851	0.00117	CcSEcCtD
Frovatriptan—Loss of consciousness—Memantine—Alzheimer's disease	0.000851	0.00117	CcSEcCtD
Frovatriptan—Syncope—Rivastigmine—Alzheimer's disease	0.000849	0.00116	CcSEcCtD
Frovatriptan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000841	0.00115	CcSEcCtD
Frovatriptan—Convulsion—Memantine—Alzheimer's disease	0.000839	0.00115	CcSEcCtD
Frovatriptan—Palpitations—Rivastigmine—Alzheimer's disease	0.000837	0.00115	CcSEcCtD
Frovatriptan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000832	0.00114	CcSEcCtD
Frovatriptan—Anorexia—Donepezil—Alzheimer's disease	0.00083	0.00114	CcSEcCtD
Frovatriptan—Hypersensitivity—Galantamine—Alzheimer's disease	0.000827	0.00113	CcSEcCtD
Frovatriptan—Arthralgia—Memantine—Alzheimer's disease	0.000824	0.00113	CcSEcCtD
Frovatriptan—Chest pain—Memantine—Alzheimer's disease	0.000824	0.00113	CcSEcCtD
Frovatriptan—Myalgia—Memantine—Alzheimer's disease	0.000824	0.00113	CcSEcCtD
Frovatriptan—Anxiety—Memantine—Alzheimer's disease	0.000821	0.00113	CcSEcCtD
Frovatriptan—Convulsion—Rivastigmine—Alzheimer's disease	0.000821	0.00112	CcSEcCtD
Frovatriptan—Discomfort—Memantine—Alzheimer's disease	0.000814	0.00112	CcSEcCtD
Frovatriptan—Myalgia—Rivastigmine—Alzheimer's disease	0.000806	0.00111	CcSEcCtD
Frovatriptan—Chest pain—Rivastigmine—Alzheimer's disease	0.000806	0.00111	CcSEcCtD
Frovatriptan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000806	0.00111	CcSEcCtD
Frovatriptan—Dry mouth—Memantine—Alzheimer's disease	0.000806	0.0011	CcSEcCtD
Frovatriptan—Asthenia—Galantamine—Alzheimer's disease	0.000806	0.0011	CcSEcCtD
Frovatriptan—Anxiety—Rivastigmine—Alzheimer's disease	0.000804	0.0011	CcSEcCtD
Frovatriptan—Confusional state—Memantine—Alzheimer's disease	0.000797	0.00109	CcSEcCtD
Frovatriptan—Discomfort—Rivastigmine—Alzheimer's disease	0.000797	0.00109	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000793	0.00109	CcSEcCtD
Frovatriptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.000789	0.00108	CcSEcCtD
Frovatriptan—Insomnia—Donepezil—Alzheimer's disease	0.000787	0.00108	CcSEcCtD
Frovatriptan—Paraesthesia—Donepezil—Alzheimer's disease	0.000781	0.00107	CcSEcCtD
Frovatriptan—Confusional state—Rivastigmine—Alzheimer's disease	0.000779	0.00107	CcSEcCtD
Frovatriptan—Shock—Memantine—Alzheimer's disease	0.000777	0.00107	CcSEcCtD
Frovatriptan—Dyspnoea—Donepezil—Alzheimer's disease	0.000776	0.00106	CcSEcCtD
Frovatriptan—Somnolence—Donepezil—Alzheimer's disease	0.000774	0.00106	CcSEcCtD
Frovatriptan—Tachycardia—Memantine—Alzheimer's disease	0.000771	0.00106	CcSEcCtD
Frovatriptan—Diarrhoea—Galantamine—Alzheimer's disease	0.000768	0.00105	CcSEcCtD
Frovatriptan—Dyspepsia—Donepezil—Alzheimer's disease	0.000766	0.00105	CcSEcCtD
Frovatriptan—Hyperhidrosis—Memantine—Alzheimer's disease	0.000764	0.00105	CcSEcCtD
Frovatriptan—Shock—Rivastigmine—Alzheimer's disease	0.000761	0.00104	CcSEcCtD
Frovatriptan—Decreased appetite—Donepezil—Alzheimer's disease	0.000757	0.00104	CcSEcCtD
Frovatriptan—Tachycardia—Rivastigmine—Alzheimer's disease	0.000754	0.00103	CcSEcCtD
Frovatriptan—Anorexia—Memantine—Alzheimer's disease	0.000753	0.00103	CcSEcCtD
Frovatriptan—Fatigue—Donepezil—Alzheimer's disease	0.00075	0.00103	CcSEcCtD
Frovatriptan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000747	0.00102	CcSEcCtD
Frovatriptan—Pain—Donepezil—Alzheimer's disease	0.000744	0.00102	CcSEcCtD
Frovatriptan—Constipation—Donepezil—Alzheimer's disease	0.000744	0.00102	CcSEcCtD
Frovatriptan—Dizziness—Galantamine—Alzheimer's disease	0.000743	0.00102	CcSEcCtD
Frovatriptan—Anorexia—Rivastigmine—Alzheimer's disease	0.000737	0.00101	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00072	0.000987	CcSEcCtD
Frovatriptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.000717	0.000983	CcSEcCtD
Frovatriptan—Insomnia—Memantine—Alzheimer's disease	0.000715	0.00098	CcSEcCtD
Frovatriptan—Vomiting—Galantamine—Alzheimer's disease	0.000714	0.000979	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000712	0.000975	CcSEcCtD
Frovatriptan—Paraesthesia—Memantine—Alzheimer's disease	0.00071	0.000972	CcSEcCtD
Frovatriptan—Dyspnoea—Memantine—Alzheimer's disease	0.000704	0.000966	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000704	0.000965	CcSEcCtD
Frovatriptan—Headache—Galantamine—Alzheimer's disease	0.000703	0.000964	CcSEcCtD
Frovatriptan—Somnolence—Memantine—Alzheimer's disease	0.000702	0.000963	CcSEcCtD
Frovatriptan—Insomnia—Rivastigmine—Alzheimer's disease	0.000699	0.000958	CcSEcCtD
Frovatriptan—Dyspepsia—Memantine—Alzheimer's disease	0.000696	0.000953	CcSEcCtD
Frovatriptan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000694	0.000951	CcSEcCtD
Frovatriptan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000689	0.000945	CcSEcCtD
Frovatriptan—Body temperature increased—Donepezil—Alzheimer's disease	0.000688	0.000943	CcSEcCtD
Frovatriptan—Abdominal pain—Donepezil—Alzheimer's disease	0.000688	0.000943	CcSEcCtD
Frovatriptan—Somnolence—Rivastigmine—Alzheimer's disease	0.000687	0.000942	CcSEcCtD
Frovatriptan—Decreased appetite—Memantine—Alzheimer's disease	0.000687	0.000941	CcSEcCtD
Frovatriptan—Fatigue—Memantine—Alzheimer's disease	0.000681	0.000934	CcSEcCtD
Frovatriptan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00068	0.000933	CcSEcCtD
Frovatriptan—Pain—Memantine—Alzheimer's disease	0.000676	0.000926	CcSEcCtD
Frovatriptan—Constipation—Memantine—Alzheimer's disease	0.000676	0.000926	CcSEcCtD
Frovatriptan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000672	0.000921	CcSEcCtD
Frovatriptan—Nausea—Galantamine—Alzheimer's disease	0.000667	0.000914	CcSEcCtD
Frovatriptan—Fatigue—Rivastigmine—Alzheimer's disease	0.000666	0.000913	CcSEcCtD
Frovatriptan—Constipation—Rivastigmine—Alzheimer's disease	0.000661	0.000906	CcSEcCtD
Frovatriptan—Pain—Rivastigmine—Alzheimer's disease	0.000661	0.000906	CcSEcCtD
Frovatriptan—Feeling abnormal—Memantine—Alzheimer's disease	0.000651	0.000892	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000646	0.000886	CcSEcCtD
Frovatriptan—Hypersensitivity—Donepezil—Alzheimer's disease	0.000641	0.000879	CcSEcCtD
Frovatriptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000637	0.000873	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000632	0.000866	CcSEcCtD
Frovatriptan—Body temperature increased—Memantine—Alzheimer's disease	0.000625	0.000856	CcSEcCtD
Frovatriptan—Abdominal pain—Memantine—Alzheimer's disease	0.000625	0.000856	CcSEcCtD
Frovatriptan—Asthenia—Donepezil—Alzheimer's disease	0.000624	0.000856	CcSEcCtD
Frovatriptan—Pruritus—Donepezil—Alzheimer's disease	0.000616	0.000844	CcSEcCtD
Frovatriptan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000611	0.000838	CcSEcCtD
Frovatriptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000611	0.000838	CcSEcCtD
Frovatriptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000595	0.000816	CcSEcCtD
Frovatriptan—Hypersensitivity—Memantine—Alzheimer's disease	0.000582	0.000798	CcSEcCtD
Frovatriptan—Dizziness—Donepezil—Alzheimer's disease	0.000575	0.000789	CcSEcCtD
Frovatriptan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00057	0.000781	CcSEcCtD
Frovatriptan—Asthenia—Memantine—Alzheimer's disease	0.000567	0.000777	CcSEcCtD
Frovatriptan—Pruritus—Memantine—Alzheimer's disease	0.000559	0.000766	CcSEcCtD
Frovatriptan—Asthenia—Rivastigmine—Alzheimer's disease	0.000555	0.00076	CcSEcCtD
Frovatriptan—Vomiting—Donepezil—Alzheimer's disease	0.000553	0.000758	CcSEcCtD
Frovatriptan—Pruritus—Rivastigmine—Alzheimer's disease	0.000547	0.00075	CcSEcCtD
Frovatriptan—Headache—Donepezil—Alzheimer's disease	0.000545	0.000747	CcSEcCtD
Frovatriptan—Diarrhoea—Memantine—Alzheimer's disease	0.000541	0.000741	CcSEcCtD
Frovatriptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000529	0.000725	CcSEcCtD
Frovatriptan—Dizziness—Memantine—Alzheimer's disease	0.000523	0.000716	CcSEcCtD
Frovatriptan—Nausea—Donepezil—Alzheimer's disease	0.000517	0.000709	CcSEcCtD
Frovatriptan—Dizziness—Rivastigmine—Alzheimer's disease	0.000511	0.000701	CcSEcCtD
Frovatriptan—Vomiting—Memantine—Alzheimer's disease	0.000502	0.000689	CcSEcCtD
Frovatriptan—Headache—Memantine—Alzheimer's disease	0.000495	0.000678	CcSEcCtD
Frovatriptan—Vomiting—Rivastigmine—Alzheimer's disease	0.000491	0.000674	CcSEcCtD
Frovatriptan—Headache—Rivastigmine—Alzheimer's disease	0.000484	0.000664	CcSEcCtD
Frovatriptan—Nausea—Memantine—Alzheimer's disease	0.000469	0.000643	CcSEcCtD
Frovatriptan—Nausea—Rivastigmine—Alzheimer's disease	0.000459	0.000629	CcSEcCtD
Frovatriptan—HTR1A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000101	0.000778	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NPY—Alzheimer's disease	0.000101	0.000772	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IAPP—Alzheimer's disease	0.0001	0.000768	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GAL—Alzheimer's disease	9.94e-05	0.000762	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GFAP—Alzheimer's disease	9.94e-05	0.000762	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CRH—Alzheimer's disease	9.71e-05	0.000745	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—SST—Alzheimer's disease	9.67e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GAB2—Alzheimer's disease	9.67e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDK5—Alzheimer's disease	9.47e-05	0.000727	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—F2—Alzheimer's disease	9.46e-05	0.000726	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—APP—Alzheimer's disease	9.42e-05	0.000723	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	9.35e-05	0.000718	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NPS—Alzheimer's disease	9.2e-05	0.000706	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	9.16e-05	0.000703	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR6—Alzheimer's disease	9.11e-05	0.000699	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—A2M—Alzheimer's disease	8.94e-05	0.000686	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	8.89e-05	0.000682	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PRKCG—Alzheimer's disease	8.82e-05	0.000677	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GAB2—Alzheimer's disease	8.78e-05	0.000674	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—SST—Alzheimer's disease	8.78e-05	0.000674	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—A2M—Alzheimer's disease	8.76e-05	0.000672	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.72e-05	0.000669	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PSEN2—Alzheimer's disease	8.66e-05	0.000665	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	8.63e-05	0.000662	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	8.58e-05	0.000659	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—APP—Alzheimer's disease	8.56e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PSEN2—Alzheimer's disease	8.48e-05	0.000651	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL2—Alzheimer's disease	8.43e-05	0.000647	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCR5—Alzheimer's disease	8.35e-05	0.000641	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PSENEN—Alzheimer's disease	8.28e-05	0.000635	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCR5—Alzheimer's disease	8.18e-05	0.000628	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.17e-05	0.000627	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APH1A—Alzheimer's disease	8.16e-05	0.000626	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	8.07e-05	0.00062	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PRKCG—Alzheimer's disease	8.01e-05	0.000614	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	8e-05	0.000614	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NPY—Alzheimer's disease	7.97e-05	0.000612	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CA4—Alzheimer's disease	7.95e-05	0.00061	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	7.94e-05	0.00061	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IAPP—Alzheimer's disease	7.92e-05	0.000608	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PRKCG—Alzheimer's disease	7.84e-05	0.000602	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NPY—Alzheimer's disease	7.8e-05	0.000599	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.77e-05	0.000596	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IAPP—Alzheimer's disease	7.76e-05	0.000595	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	7.75e-05	0.000595	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CRH—Alzheimer's disease	7.69e-05	0.00059	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCR5—Alzheimer's disease	7.59e-05	0.000582	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	7.57e-05	0.000581	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	7.57e-05	0.000581	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CRH—Alzheimer's disease	7.53e-05	0.000578	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	7.48e-05	0.000574	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR5—Alzheimer's disease	7.43e-05	0.00057	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—Alzheimer's disease	7.42e-05	0.00057	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NPS—Alzheimer's disease	7.29e-05	0.000559	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—Alzheimer's disease	7.27e-05	0.000558	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PPP3CA—Alzheimer's disease	7.25e-05	0.000557	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—F2—Alzheimer's disease	7.17e-05	0.00055	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTK2B—Alzheimer's disease	7.15e-05	0.000549	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NPS—Alzheimer's disease	7.14e-05	0.000548	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PPP3CA—Alzheimer's disease	7.1e-05	0.000545	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	7.09e-05	0.000544	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—F2—Alzheimer's disease	7.02e-05	0.000539	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTK2B—Alzheimer's disease	7e-05	0.000537	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NTRK2—Alzheimer's disease	6.95e-05	0.000534	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GAB2—Alzheimer's disease	6.95e-05	0.000534	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SST—Alzheimer's disease	6.95e-05	0.000534	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CALM1—Alzheimer's disease	6.93e-05	0.000531	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GSK3A—Alzheimer's disease	6.89e-05	0.000529	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GAB2—Alzheimer's disease	6.81e-05	0.000523	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NTRK2—Alzheimer's disease	6.81e-05	0.000523	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SST—Alzheimer's disease	6.81e-05	0.000523	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CALM1—Alzheimer's disease	6.78e-05	0.00052	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APP—Alzheimer's disease	6.78e-05	0.00052	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLD3—Alzheimer's disease	6.76e-05	0.000519	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.76e-05	0.000519	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GSK3A—Alzheimer's disease	6.75e-05	0.000518	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.68e-05	0.000513	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	6.67e-05	0.000512	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APP—Alzheimer's disease	6.64e-05	0.000509	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.58e-05	0.000505	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—F2—Alzheimer's disease	6.51e-05	0.000499	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	6.48e-05	0.000497	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	6.46e-05	0.000496	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PLCB1—Alzheimer's disease	6.39e-05	0.000491	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—F2—Alzheimer's disease	6.37e-05	0.000489	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.34e-05	0.000486	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PLCB1—Alzheimer's disease	6.26e-05	0.000481	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	6.24e-05	0.000479	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	6.23e-05	0.000478	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.1e-05	0.000468	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ND1—Alzheimer's disease	6.03e-05	0.000462	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	5.97e-05	0.000458	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NGFR—Alzheimer's disease	5.97e-05	0.000458	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	5.95e-05	0.000456	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CREB1—Alzheimer's disease	5.93e-05	0.000455	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	5.91e-05	0.000453	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.89e-05	0.000452	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NGFR—Alzheimer's disease	5.84e-05	0.000448	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADAM10—Alzheimer's disease	5.83e-05	0.000447	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CREB1—Alzheimer's disease	5.81e-05	0.000445	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL2—Alzheimer's disease	5.8e-05	0.000445	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	5.74e-05	0.00044	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADAM10—Alzheimer's disease	5.71e-05	0.000438	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL2—Alzheimer's disease	5.68e-05	0.000436	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	5.66e-05	0.000434	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	5.54e-05	0.000425	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—S100B—Alzheimer's disease	5.51e-05	0.000423	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	5.44e-05	0.000417	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	5.41e-05	0.000415	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—S100B—Alzheimer's disease	5.4e-05	0.000414	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.39e-05	0.000413	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	5.35e-05	0.00041	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	5.33e-05	0.000409	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF2—Alzheimer's disease	5.25e-05	0.000403	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SST—Alzheimer's disease	5.19e-05	0.000398	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	5.19e-05	0.000398	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	5.19e-05	0.000398	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	5.17e-05	0.000396	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	5.14e-05	0.000395	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF2—Alzheimer's disease	5.14e-05	0.000394	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1R—Alzheimer's disease	5.07e-05	0.000389	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APP—Alzheimer's disease	5.06e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1R—Alzheimer's disease	4.97e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LPL—Alzheimer's disease	4.86e-05	0.000373	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	4.85e-05	0.000373	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MEF2C—Alzheimer's disease	4.82e-05	0.00037	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	4.77e-05	0.000366	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LPL—Alzheimer's disease	4.76e-05	0.000365	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCG—Alzheimer's disease	4.73e-05	0.000363	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MEF2C—Alzheimer's disease	4.72e-05	0.000362	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.64e-05	0.000356	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCG—Alzheimer's disease	4.63e-05	0.000355	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NGF—Alzheimer's disease	4.61e-05	0.000354	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NGF—Alzheimer's disease	4.51e-05	0.000346	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR5—Alzheimer's disease	4.48e-05	0.000344	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	4.45e-05	0.000342	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	4.42e-05	0.000339	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR5—Alzheimer's disease	4.39e-05	0.000337	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—Alzheimer's disease	4.39e-05	0.000337	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	4.35e-05	0.000334	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	4.33e-05	0.000332	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—Alzheimer's disease	4.29e-05	0.00033	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.23e-05	0.000324	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	4.11e-05	0.000315	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CALM1—Alzheimer's disease	4.09e-05	0.000314	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—Alzheimer's disease	4.08e-05	0.000313	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—Alzheimer's disease	4.08e-05	0.000313	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CAV1—Alzheimer's disease	4.04e-05	0.00031	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CALM1—Alzheimer's disease	4.01e-05	0.000307	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—Alzheimer's disease	3.99e-05	0.000306	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—Alzheimer's disease	3.99e-05	0.000306	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CAV1—Alzheimer's disease	3.96e-05	0.000304	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	3.91e-05	0.0003	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ESR1—Alzheimer's disease	3.89e-05	0.000299	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CHAT—Alzheimer's disease	3.88e-05	0.000298	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TPI1—Alzheimer's disease	3.88e-05	0.000298	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—F2—Alzheimer's disease	3.84e-05	0.000295	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ESR1—Alzheimer's disease	3.81e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	3.78e-05	0.00029	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—F2—Alzheimer's disease	3.76e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	3.76e-05	0.000289	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MAOB—Alzheimer's disease	3.72e-05	0.000286	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.68e-05	0.000283	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	3.63e-05	0.000278	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	3.6e-05	0.000276	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	3.58e-05	0.000275	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.54e-05	0.000272	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	3.53e-05	0.000271	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	3.53e-05	0.000271	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.51e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	3.5e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—Alzheimer's disease	3.48e-05	0.000267	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—A2M—Alzheimer's disease	3.46e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	3.46e-05	0.000265	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	3.44e-05	0.000264	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	3.43e-05	0.000263	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	3.43e-05	0.000263	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—Alzheimer's disease	3.41e-05	0.000262	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	3.37e-05	0.000259	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	3.36e-05	0.000257	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	3.34e-05	0.000257	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	3.3e-05	0.000253	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	3.27e-05	0.000251	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.09e-05	0.000237	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	3.05e-05	0.000234	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	3.05e-05	0.000234	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	3.04e-05	0.000233	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	3.04e-05	0.000233	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	3.01e-05	0.000231	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.01e-05	0.000231	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	2.99e-05	0.00023	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.98e-05	0.000228	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	2.9e-05	0.000223	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—F2—Alzheimer's disease	2.87e-05	0.00022	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.82e-05	0.000217	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.82e-05	0.000217	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.81e-05	0.000215	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.77e-05	0.000212	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.63e-05	0.000202	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.62e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2.62e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.61e-05	0.0002	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—Alzheimer's disease	2.6e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	2.59e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	2.58e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.56e-05	0.000197	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.56e-05	0.000196	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	2.54e-05	0.000195	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	2.52e-05	0.000194	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.51e-05	0.000193	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.47e-05	0.00019	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.43e-05	0.000186	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.4e-05	0.000184	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.38e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.38e-05	0.000182	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.33e-05	0.000179	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.33e-05	0.000179	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.28e-05	0.000175	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	2.2e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.15e-05	0.000165	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.07e-05	0.000159	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.06e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	2.02e-05	0.000155	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.98e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.95e-05	0.00015	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.93e-05	0.000148	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.92e-05	0.000147	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.88e-05	0.000144	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.78e-05	0.000136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.77e-05	0.000136	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.69e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.66e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.64e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.63e-05	0.000125	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.58e-05	0.000122	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.58e-05	0.000121	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.56e-05	0.00012	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.52e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.51e-05	0.000116	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.49e-05	0.000114	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.4e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-05	0.000105	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.37e-05	0.000105	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—Alzheimer's disease	1.35e-05	0.000103	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.24e-05	9.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.18e-05	9.07e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.14e-05	8.71e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.08e-05	8.3e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-05	8.04e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.43e-06	4.17e-05	CbGpPWpGaD
